Companion Diagnostics Market Size, Share, Demand, Key Players, Growth and Industry Trends 2023-28

According to the latest report by IMARC Group, titled “Companion Diagnostics Market Share: Global Industry Trends, Size, Growth, Opportunity and Forecast 2023-2028,” The global companion diagnostics market size reached US$ 5.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.3 Billion by 2028, exhibiting a growth rate (CAGR) of 14.4% during 2023-2028.

Companion diagnostics are a range of tests that help to match a patient to a particular therapy or drug. These tests are performed through an in-vitro medical device that offers essential information for the safe and effective use of a corresponding drug or biological product. These tests help in diagnosing different categories of diseases, including infectious, neurological, and cardiovascular diseases. Consequently, companion diagnostics are extensively utilized by laboratories, pharmaceuticals, and research institutes.

Global Companion Diagnostics Market Trends:

The rising demand for personalized medicine across the globe is majorly driving the companion diagnostics market growth. The rising awareness regarding the discovery of new biomarkers for diverse medical conditions are further contributing to the market growth. In line with this, an increasing numbercases of adverse drug reactions (ADRs) due to the lack of efficacy of treatment methods are fueling the market growth. Furthermore, rising research and development (R&D) activities for the development of novel diagnostic tests for chronic diseases are creating a positive outlook for the market.

Request Free Sample Report: https://www.imarcgroup.com/companion-diagnostics-market/requestsample

Global Companion diagnostic Market 2023-2028 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Abbott Laboratories, Agilent Technologies, BioMerieux, Danaher Corporation, Roche Holding AG, Myriad Genetics Inc., Siemens Healthcare and Thermo Fisher Scientific Inc.

The report has segmented the market on the basis on region, product & services, technology, indication and end-user.

Breakup by Product & Service:

Breakup by Technology:

Breakup by Indication:

Breakup by End User:

Breakup by Region:

Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2548&flag=C

Key highlights of the report:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

Company Name: IMARC Group

Email: sales@imarcgroup.com

Toll Free Number: USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 30 N Gould St, Ste R

Sheridan, WY 82801, USA

Website: https://www.imarcgroup.com/

Follow us on twitter: @imarcglobal

Linkedin: https://www.linkedin.com/company/imarc-group